Three new organ preservation systems allow transplant surgeons to travel farther distances to procure donor livers and provide the ability to better assess potential donor livers that may have borderline function. Through the use of these new preservation systems, Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute has greatly expanded its options for accepting donor livers, especially extended criteria livers that may not have been accepted in the past.
Living liver donors report an immense emotional and spiritual benefit from knowing they are saving the life of a loved one. However, it is impossible to overlook the surgical trauma, cosmetic scars and surgical risks to which otherwise healthy donors are exposed with this major operation. To mitigate the potential harm to donors, Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute has begun performing robotic living donor hepatectomies, one of only two programs in the United States to do so. The transplant team recently performed its 21st robotic living donor hepatectomy.
The burden of liver disease is increasing in Dallas/Fort Worth and throughout the nation. In addition to alcohol abuse or misuse, there has been an alarming increase in the incidence of non-alcoholic fatty liver disease, a leading cause of cirrhosis.
Acuity circles (AC) liver allocation policy was implemented to eliminate donor service area geographic boundaries from liver allocation and to decrease variability in median model of end-stage liver disease (MELD) score at transplant and wait list mortality. A team of researchers at Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute found that the new policy also significantly increased transportation costs and acquisition fees.
While the number of organ donations after circulatory death (DCD) continues to grow in the United States and worldwide, it is yet to be accepted universally as a viable option to serve patients on the waiting list. Donation after circulatory death was the topic of the 7th Innovations in Transplant Summit, hosted April 22 and 23 by Baylor University Medical Center (Baylor Dallas), part of Baylor Scott & White Health.
